BriaCell Therapeutics Corp. Stock price Nasdaq
Equities
BCTX
CA1079301091
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.815 USD | +5.43% | +22.37% | -52.31% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 42.69M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -22M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.38
x | P/E ratio 2025 * |
-2.54
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.83% |
1 day | +5.43% | ||
1 week | +22.37% | ||
Current month | -19.36% | ||
1 month | -17.94% | ||
3 months | -48.99% | ||
6 months | -52.23% | ||
Current year | -52.31% |
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 16-10-31 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 16-01-31 |
Chief Tech/Sci/R&D Officer | 53 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 16-05-09 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-08-30 |
Rebecca Taub
BRD | Director/Board Member | 71 | 18-03-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.79 | +4.49% | 33 438 |
24-03-27 | 2.67 | +5.12% | 85,183 |
24-03-26 | 2.54 | -10.88% | 146,432 |
24-03-25 | 2.85 | +13.10% | 190,437 |
24-03-22 | 2.52 | +10.53% | 138,875 |
Delayed Quote Nasdaq, March 28, 2024 at 02:51 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.98% | 108B | |
+9.93% | 104B | |
+6.58% | 23.66B | |
-12.42% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.20% | 16.19B | |
+4.85% | 13.72B | |
+34.69% | 12.22B |
- Stock
- Equities
- Stock BriaCell Therapeutics Corp.
- Stock BriaCell Therapeutics Corp. - Nasdaq